Investors in Salt Lake City-based vitamin maker Schiff Nutrition International (NYSE:SHF) saw a huge windfall Wednesday following news that SHF is planning to sell itself to Germany’s Bayer AG (PINK:BAYRY) for $1.1 billion.
Schiff’s shareholders are due to receive $34 per share in cash — 47% above the closing price on Oct. 26, 2012. Schiff did not elect to pursue other offers but does have the right to look at unsolicited competing bids through Nov. 28.
The move will bring brands like Schiff vitamins, MegaRed and Move Free — as well as Tiger’s Milk — under the fold of Bayer’s consumer health unit. All in all, Schiff could add around $260 million in sales based on 2011 results, though the company expected revenue growth of between 43% and 46% bolstered by its purchase of cold-prevention drug Airborne, according to Bloomberg.
SHF shares are up 45% in today’s trading.
More from pharmaceuticals:
- Bad News for These Two Pharmaceuticals
- Bayer to Buy Teva’s U.S. Animal Health Unit for $145M